Embracing Change Together: Adapting to Price Pressures, Regulatory Shifts, and Technology Revolution for Accelerated Biopharma Time-to-Market | 2023 Digital CMC Summit On-Demand | Presentation
How forward-thinking drug developers are leading the way by embracing Digital CMC principles and technology
How a burgeoning tech stack is accelerating CMC's transformation into a true digital ecosystem
How the industry's digital leaders reshaping their organizational cultures and embracing modern regulatory frameworks
How these shifts have exponentially advanced productivity across development, approval, and manufacturing phases
Adapting to Price Pressures, Regulatory Shifts & a Technology Revolution
In the opening minutes of the 2023 Digital CMC Summit, Daniel R. Matlis, Founder and President of Axendia, stepped up and hit the room between the eyes: change is happening faster than ever, and it’s time for the life sciences to accept and welcome it. Not prepare for it or evaluate it, but embrace it as one industry committed to improving patient outcomes.
You won't want to miss this thought-provoking introduction to the Summit, or Daniel’s compelling case of collaboration across companies, departments, regulatory frameworks, and markets. In his opening presentation, he takes a bracing look at:
- The growing challenges and accelerating changes that are pushing drug developers, technology innovators, and regulators to embrace transformation
- How competitive, regulatory, and economic pressures are finally breaking down industry silos and driving a shift toward holistic life cycle approaches
- Where regulators like the FDA are using their leverage to promote digitalization, advance innovation, and push the industry toward harmonization
- Why now is the time to unify around industry-scale efforts to establish data management standards, harness AI innovation, and address major challenges like pricing reform
Register today to watch his full keynote!
Session speakers
Watch this session
We’re here to help you deliver
